Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 11, 2022

SELL
$12.41 - $32.42 $56,651 - $147,997
-4,565 Reduced 16.61%
22,915 $284,000
Q2 2022

Jul 08, 2022

SELL
$19.63 - $26.62 $5,692 - $7,719
-290 Reduced 1.04%
27,480 $539,000
Q1 2022

Apr 13, 2022

SELL
$24.65 - $29.0 $41,905 - $49,300
-1,700 Reduced 5.77%
27,770 $725,000
Q4 2021

Jan 11, 2022

BUY
$27.74 - $34.09 $106,105 - $130,394
3,825 Added 14.92%
29,470 $836,000
Q2 2021

Jul 12, 2021

SELL
$28.76 - $35.98 $2.24 Million - $2.8 Million
-77,900 Reduced 75.23%
25,645 $890,000
Q1 2021

Apr 13, 2021

SELL
$27.85 - $34.49 $2.86 Million - $3.54 Million
-102,580 Closed
0 $0
Q4 2020

Jan 07, 2021

BUY
$27.53 - $33.79 $1.67 Million - $2.05 Million
60,555 Added 144.09%
102,580 $3.15 Million
Q3 2020

Oct 09, 2020

BUY
$21.1 - $29.13 $886,727 - $1.22 Million
42,025 New
42,025 $1.17 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.42B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Norman Fields, Gottscho Capital Management, LLC Portfolio

Follow Norman Fields, Gottscho Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norman Fields, Gottscho Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Norman Fields, Gottscho Capital Management, LLC with notifications on news.